Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.

Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.

Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.

Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.

Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.

Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.

A comparison of antiangiogenic therapies for the prevention of liver metastases.

Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.

[CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance].

Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo.

[A study of human enteric nervous system development in the middle stage of embryogenesis].

Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests.

The development of colon innervation in trisomy 16 mice and Hirschsprung's disease.